CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Exec. VP Chief Legal Officer sold 58,163 shares at $9.04 ($525,590)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 14,479 shares (option exercise)
- 4 Option exercise Director acquired 25,791 shares (option exercise)
- SD Other Specialized Disclosure
- 4 Open-market sale Executive VP, Global R&D sold 130,000 shares at $8.22 ($1,068,067)
Page 25 of 128 · 2,555 filings